Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeObject Symbol | Species | Term | Qualifier | Evidence | With | Notes | Source | Original Reference(s) | Mmp2 | Rat | abnormal podocyte physiology | ameliorates | IMP | | associated with Experimental Diabetes Mellitus and compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | abnormal podocyte physiology | ameliorates | IMP | | associated with Experimental Diabetes Mellitus and compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | abnormal podocyte physiology | ameliorates | IMP | | associated with Experimental Diabetes Mellitus and compared to wild type SS | RGD | | Mmp2 | Rat | decreased circulating creatinine level | | IMP | | compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | decreased circulating creatinine level | | IMP | | compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | decreased circulating creatinine level | | IMP | | compared to wild type SS | RGD | | Mmp2 | Rat | decreased kidney weight | | IMP | | associated Experimental Diabetes Mellitus more ... | RGD | | Mmp2em2Mcwi | Rat | decreased kidney weight | | IMP | | associated Experimental Diabetes Mellitus more ... | RGD | | SS-Mmp2em1Mcwi-/- | Rat | decreased kidney weight | | IMP | | associated Experimental Diabetes Mellitus more ... | RGD | | Mmp2 | Rat | decreased transforming growth factor beta level | | IMP | | compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | decreased transforming growth factor beta level | | IMP | | compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | decreased transforming growth factor beta level | | IMP | | compared to wild type SS | RGD | | Mmp2 | Rat | decreased urine protein level | | IMP | | compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | decreased urine protein level | | IMP | | compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | decreased urine protein level | | IMP | | compared to wild type SS | RGD | | Mmp2 | Rat | decreased vascular permeability | ameliorates | IMP | | associated with Experimental Diabetes Mellitus and compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | decreased vascular permeability | ameliorates | IMP | | associated with Experimental Diabetes Mellitus and compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | decreased vascular permeability | ameliorates | IMP | | associated with Experimental Diabetes Mellitus and compared to wild type SS | RGD | | Mmp2 | Rat | glomerulosclerosis | ameliorates | IMP | | compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | glomerulosclerosis | ameliorates | IMP | | compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | glomerulosclerosis | ameliorates | IMP | | compared to wild type SS | RGD | | Mmp2 | Rat | increased renal glomerular filtration rate | | IMP | | compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | increased renal glomerular filtration rate | | IMP | | compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | increased renal glomerular filtration rate | | IMP | | compared to wild type SS | RGD | | Mmp2 | Rat | renal interstitial fibrosis | ameliorates | IMP | | compared to wild type SS | RGD | | Mmp2em2Mcwi | Rat | renal interstitial fibrosis | ameliorates | IMP | | compared to wild type SS | RGD | | SS-Mmp2em1Mcwi-/- | Rat | renal interstitial fibrosis | ameliorates | IMP | | compared to wild type SS | RGD | | |